-
Merck Settlement For Vioxx Cases Said To Be Several Years Away
UPDATE: Global Settlement Offer Made By Merck To End Vioxx Litigation According To November 9, 2007 News Reports Merck Agrees to Settle Vioxx Suits for $4.85 Billion (NY Times) Merck Is Expected to Announce…
-
Ortho Evra: More Women Sue J&J Over Birth Control Patch
Lawsuits Allege Serious Blood Clots Conditions Such As Pulmonary Embolism, With One Young Woman Dying From Using Ortho Evra In early November 2006 two new California Ortho Evra lawsuits were filed in San Francisco…
-
Natrecor: Safety Concerns And Off-Label Investigation Plague Scios And J&J
Medical Journal Articles About Natrecor And Renal Failure May Have Been Cause Of Reduced Natrecor Use In Late 2005 Steve Johnson provides some insights about the so-called "off-label" use of prescription drugs with his…
-
Case Reports: Serious Blood Sugar Problems In Patients Taking Tequin
Article Finds Tequin Is "Probable Cause" of Hyperglycemia And Hypoglycemia, Or Dysglycemia, In Most Of Subject Cases There is a Case Reports article concerning Tequin (gatifloxacin) causing serious blood-sugar problems, or dysglycemia, in the…
-
Health Canada’s MedEffect Now Offers Online Reporting Of Adverse Drug Reactions
Objective Is To Increase Percentage Of ADRs That Get Reported To Regulators In October 2006 Health Canada announced that its MedEffect web site is now able to accept online reports of suspected adverse drug…
